Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma. Tang Q, Xu F, Lin J, Zhang C, et al. Exp Eye Res 2022 Aug 27:109221. doi: 10.1016/j.exer.2022.109221.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang Q, Xu F, Lin J, Zhang C, et al. Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma. Exp Eye Res 2022 Aug 27:109221. doi: 10.1016/j.exer.2022.109221.
PMID: 36041510